Related Experiment Video
Updated: Jul 18, 2026

11:35
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
57.9K
Quantitative Susceptibility Mapping Values Quantification in Deep Gray Matter Structures for Relapsing-Remitting
Sana Mohammadi1, Sadegh Ghaderi1,2, Farzad Fatehi1,3
1Neuromuscular Research Center, Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Brain and Behavior
|October 17, 2024
Summary
Quantitative susceptibility mapping (QSM) reveals altered iron levels in deep gray matter (DGM) structures in relapsing-remitting multiple sclerosis (RRMS) patients. These magnetic susceptibility (χ) changes in the putamen, globus pallidus, and caudate nucleus may indicate neurodegeneration.
Area of Science:
- Neuroimaging
- Neurodegeneration
- Multiple Sclerosis Research
Background:
- Deep gray matter (DGM) iron dysregulation is implicated in multiple sclerosis (MS) pathogenesis.
- Quantitative susceptibility mapping (QSM) is a novel MRI technique to assess iron levels.
- Relapsing-remitting MS (RRMS) is the most common form of MS, characterized by distinct neurological episodes.
Purpose of the Study:
- To systematically review and meta-analyze the role of magnetic susceptibility (χ) in DGM structures (putamen, globus pallidus, caudate nucleus, thalamus) in RRMS.
- To utilize QSM to quantify susceptibility differences between RRMS patients and healthy controls (HCs).
- To explore potential biomarkers for neurodegeneration in RRMS.
Main Methods:
- Systematic literature review up to November 2023 following PRISMA guidelines.
- Random-effects model meta-analysis to calculate standardized mean difference (SMD) in QSM values.
- Assessment of publication bias and risk of bias.
Main Results:
- Significantly higher QSM values (indicating increased iron) were observed in the putamen, globus pallidus, and caudate nucleus of RRMS patients compared to HCs.
- No significant QSM differences were found in the thalamus between RRMS patients and HCs.
- Subgroup analyses revealed that younger RRMS patients (<40 years) and those with higher male proportions exhibited more pronounced susceptibility changes in the putamen, globus pallidus, and caudate nucleus. Thalamic QSM decreased in older RRMS patients (>40 years) and those with higher male proportions. Early-stage RRMS showed higher QSM in basal ganglia, while later stages showed lower QSM in the thalamus.
Conclusions:
- QSM can serve as a valuable biomarker for detecting iron dysregulation in DGM structures in RRMS.
- Altered magnetic susceptibility in the basal ganglia nuclei (putamen, globus pallidus, caudate nucleus) is a key feature of RRMS.
- QSM findings highlight the potential role of iron dysregulation and neurodegeneration in the pathophysiology of RRMS.

